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Abstract 
 In this work, an ontology-based model for AI-assisted medicine side-effect (SE) prediction 
is developed, where three main components, including the drug model, the treatment model, 
and the AI-assisted prediction model, of proposed model are presented. To validate the 
proposed model, an ANN structure is established and trained by two hundred and forty-two 
TCM prescriptions. These data are gathered and classified from the most famous ancient TCM 
book and more than one thousand SE reports, in which two ontology-based attributions, hot 
and cold, are introduced to evaluate whether the prescription will cause SE or not. The results 
preliminarily reveal that it is a relationship between the ontology-based attributions and the 
corresponding predicted indicator that can be learnt by AI for predicting the SE, which suggests 
the proposed model has a potential in AI-assisted SE prediction. However, it should be noted 
that, the proposed model highly depends on the sufficient clinic data, and hereby, much deeper 
exploration is important for enhancing the accuracy of the prediction. 
1. Introduction 
Artificial intelligence is a modern technology that is utilized in various fields of medicine [1–
3]. At the meantime, Chinese Traditional Medicine (TCM) is now widely considered as a 
promising alternative medicine for complementary treatment in cancers or chronic diseases due 
to the effective methodology practically developed by generations of doctors for almost 4000 
years [4]. Based on previous verification, it is undeniable that there are many correlations 
between the TCM syndromes and western diseases, turning out novel approaches for enhancing 
the treatment efficiency and developing medicines regarding with TCM methodologies [5]. 
Unfortunately, hindered by the remarkable gap between the modern informatics and the 
fundament of TCM - antient Chinese philosophy, such correlations are still too elusive to be 
formulated precisely. 
Recently, in order to figure out the deep connection between modern science and TCM, the 
research combining TCM with AI for valid knowledge acquisition and mining attracts extremely 
attention, and hereby, leading to many profound works, such as ontology information system 
design [6], latent tree models design [7], TCM warehouse for AI application [8], and digital 
knowledge graph development [2]. Especially, in the view of algorithms, these AI-assisted 
techniques can be recognized by two different approaches: pattern classification and knowledge 
mining. The former technology attempts to recognize the correct pathological information such 
as pulse condition [9–14] and tongue diagnosis [15] of an individual patient. Whereas the later 
one, knowledge mining, mainly focuses on finding out various kinds of hidden relationships in 
the knowledge, for example, the relationships between symptom and symptom, symptom and 
syndrome, and, syndrome and disease [16–20]. In addition, it should be noted that there are 
many other studies that deserve attention as well, such as classifying herbs by convolutional 
neural network model [21], using deep learning mode to explore the relationship between 
herbal property and action [22]. 
On the other hand, researchers face, however, many difficulties in setting up AI for TCM in 
terms of directly interpreting TCM semantic system (almost recorded by ancient Chinese 
doctrines) into structured database. Because in this way, considerable workload must be 
undertaken by limited numbers of experts who are proficient in both AI and TCM to translate 
the TCM terminologies and then formulate the modern model thereof. In contrast, as shown in 
Fig. 1, using TCM methodology, but not the modern one, in overcoming the barriers of modern 
science, designing new medicine for example, is relatively lacking and thus of significant worth 
to explore. 
 
Fig. 1. The development procedure based on modern science and the TCM-based ontology 
In this paper, an ontology-based model is developed to train AI for drug side-effect (SE) 
prediction, in which the methodology of TCM including syndromes differentiation is applied to 
determine the ontology-based attributions and optimize the AI components, and consequently, 
form a novel scheme of effectively predicting the medicine’s attribution. Here, limited by the 
shortage of accurate clinic experiment data of modern medicine, TCM data in famous ancient 
books are used to verify the model which shows a tremendous potential in medicine discovery. 
The paper is organized as follows: in methodology section, three main components, including 
the drug model, the treatment model, and the AI-assisted prediction model, are established to 
introduce how to use TCM theory to explore the modern drugs; and then in experiment section, 
an artificial neural network (ANN)-based AI model is established and trained by the collected 
data; in the discussion section, the prediction performance in the proposed model framework is 
shown and discussed. 
2. Methodology 
2.1. The ontology-based drug model 
The artificial intelligence model proposed in this paper is based on Ontology that considers 
the essence of a certain entity as a combination of several fundamental attributions with 
corresponding values and relationships [2,23,24]. Such attributions are not only the definite 
properties which are already completely recognized by researchers, but also the latent 
properties including unknown information and relationships.  
For example, as shown in Fig.2, each drug has certain attributions including the definite ones 
and latent others, which are all involved in a certain prescription with sufficient records of clinical 
effects. In addition, assuming our prepared ontology system is complete and exclusive, a new 
drug or prescription which contains attributions we have already recorded can be depicted easily 
in the ontology-based semantic system, where we could focus on the superficial relationship 
between such attributions, or in another word labels, and effects caused thereby. In other words, 
we avoid literally figuring out the ingredient and other deeper properties of each attribution in 
the new drug, and therefore, the attribution-effect pair is crucial and could be easily converted 
into an AI scheme such as ANN to handle the prediction of the treatment. Moreover, the 
proposed ontology-based attribution model could be revised by more accurate clinic records 
automatically with AI assistance due to the intentionally fuzzy and dynamic defined latent 
attributions. In this paper, as discussed later, two items, Hot and Cold, are presented as the 
fundamental attributions of any medicines. 
 Fig. 2. Ontology-based drug model and latent attributions thereof 
2.2. The ontology-based treatment model 
 
Fig. 3. Ontology-based treatment model concerning the attribution-indicator relationships 
Based on the proposed drug model, it can be depicted as Fig. 3 that the model of the 
treatment procedure via a certain prescription X. This prescription contains several drugs 
including the attributions of known ingredients and the latent attributions. As shown in Fig. 3, 
the latent attributions own the capability of influencing the group of indicators with different 
unknown path and efficiency. In another word, in this model, the results of the treatment of a 
certain patient X that is defined as the positive or negative change of the corresponding 
indicator are the comprehensive synthesis of the effects induced by various latent attributions. 
Therefore, this procedure could be interpreted into a TCM-based semantic entities: attribution-
indicator pairs performing the effects. It should be noted that the different attributions maybe 
dominate in influencing the same indicator. Furthermore, the model is compatible with the 
known ingredients or explored attributions and the effects thereof. 
2.3. AI assisted prediction model 
Based on the drug/prescription and treatment models aforementioned, as illustrated in Fig. 
4, the SE prediction of new drug X is realized by comprehensive consideration of the involved 
ontology-based latent attributions with their influential factors (IFs) revised by sufficient 
medicines’ clinic records that contain, for instance, the attribution No. 3 and X, where the revision 
procedure could be undertaken by AI scheme such as ANN. Also, the same AI scheme could 
predict the SE with the trained pattern. 
It should be noted that the IFs must be linked with the corresponding attributions and 
indicators which means the trained model is consisted of IFs-indicator vectors but not the 
isolated IFs as the input. In this way, the ontology-based model that the latent attributions with 
corresponding IFs influence a certain indicator is established. Next, we will generate an AI 
scheme to validate our proposed model by determining two latent attributions which are hot 
and cold of the prescription, and a simple indicator: whether the prescription causes SE or not 
when this prescription is used in a right way. 
 
Fig. 4. The network for training AI using proposed models 
3. Experiment detail 
 
Fig. 5. The SE prediction procedure of proposed model 
According to the analysis in section 2, it is the key of establishing the proposed model that 
determines the attributions and obtains the IFs-indicator vectors. However, owning to the lack 
of related theory, generating the attributions directly, comprehensively, and exclusively is very 
hard. Therefore, we follow the theory of TCM which has the advantage in matured ontology-
based semantic system that can determine the attributions spontaneously. For example, Hot 
and Cold are two main attributions catalogized by TCM theory, where all the drugs must contain 
one out of these two attributions, leading to a charming approach for determining the latent 
attributions of western drugs in the same way. 
As shown in Fig. 5, after the identification of the attributions and indicators, we should 
establish and train the AI model. Here, we gathered the detailed data, including 150 effective 
prescriptions, the dosages thereof and the corresponding indicators, from a famous antient TCM 
book Shanghanzabinglun (Treatise on Cold Pathogenic and Miscellaneous Diseases) which is 
considered as the origin of practical TCM prescription in clinic. In addition, as concluded before, 
according to the practice identification by antient TCM doctors and the TCM standards 
published by Chinese government [25,26], we labeled two ontology-based attributions that are 
Hot and Cold for describing the drugs’ fundamental property, which is the first step of 
conducting the prediction as depicted in Fig. 5. Thereafter, we assigned the IFs of each 
attribution equaling to the total dosage of the drugs which own the corresponding attribution 
in the prescription. Since in the ontology-based labeling procedure, a drug must belong to one 
certain catalogue out of the two in total, using the summarized dosage to represent the IFs is 
reasonable, however, it needs more verification in future research. In addition, it should be noted 
that some prescriptions do not contain any drugs (for example some un- catalogued pure 
chemical ingredients) associated with Hot or Cold, where for convenience these drugs could be 
considered as neutral ones and not affiliated with the two attributions mentioned before. 
 Fig. 6. The counts of the hot/cold IF (counts) in the book 
As shown in Fig. 6(a), 242 effective prescriptions are dotted regarding with the normalized 
total dosage, where the x-axis and y-axis in the figure represent the total hot dosage and the 
total cold dosage respectively. These dosages are considered as the IF factors of the prescription. 
According to our best knowledge, because there are no reports indicating the 150 prescriptions 
gathered from the book Shanhanzabinglun, we consider these prescriptions are the safe 
prescriptions. In contrast, we gathered 92 unsafe prescriptions reported to frequently cause SE 
when they are used in a right way. 
The distribution of the percentages of the safe prescriptions and the unsafe prescriptions 
features a huge difference in terms of whether the dosage is stronger than 500, which suggests 
the reported unsafe prescriptions own the characteristics that can be distinguished from the 
safe prescriptions. Therefore, we try to use the pattern recognition method to build a simple 
classifier to predict which prescription is unsafe. 
ANN is a classic model in pattern recognition tasks. Due to its good performance and simple 
form, it is widely used in solving nonlinear classification problems. Here, a multilayer ANN model 
is developed to learn how to recognize the special pattern from our collected prescription data. 
In order to use ANN model to train this classifier, we represent each prescription into a 
vector. We analysis each prescription and identify dosages about every single herbal drug which 
form the prescription. According to “ Chinese Pharmacopoeia ” , we can clarify hot/cold 
properties of each drug appearing in our collected prescriptions. We use the weighted BOW 
model to represent prescription, 𝑣𝑝  [27,28]. Furthermore, we generate a weighted matrix 
according to the BOW model, 𝑊. The matrix W has two columns, each column in W represent 
a type of property, each row in W represent the hot or cold property on a single drug. We use 
this model generated matrix as a linear operator to generate the input vector in ANN model. 
Thus, the input vector of ANN model can be expressed as follows: 
 𝑣𝑖 = 𝑊
𝑇 . 𝑣𝑝 (1) 
where 𝑣𝑖 is input vector in the ANN model. The procedure is shown in Fig 7: 
 Fig. 7. The procedure of represent prescription into a vector 
As shown in Fig.8, the model consists of 5 layers where the input and output layer both 
contain two units for receiving the dosage vectors and accordingly yielding the SE prediction 
vectors. The three hidden layers that totally have more than 60 units with enough parameters 
are used to fit the complex relationships among ontology-based attributes, which are Cold and 
Hot here, and the affections thereof.  
 
Fig. 8. The schematic structure of the ANN and the dataflow 
To train this ANN model, we prepared and washed 150 safe prescriptions from the book 
Shanhanzabinglun and 92 reported prescriptions that frequently cause SE as mentioned before 
[29–34]. For convenience, we adopted 10-fold cross-validation to train our model, and then we 
got a convincible result as shown in Section 4. 
4. Result and discussion 
Table. 1. The results of 10-fold cross-validation. 
Fold N SE SP ACC 
1 1.00 0.00 0.92 
2 1.00 0.33 0.92 
3 0.92 1.00 0.92 
4 1.00 0.33 0.92 
5 0.91 0.00 0.88 
6 1.00 0.00 0.79 
7 1.00 0.00 0.92 
8 1.00 0.00 0.88 
9 1.00 0.00 0.79 
10 0.95 0.00 0.79 
average 0.98 0.17 0.87 
 
As seen in Table. 1, where bold values highlight the average results obtained in this research, 
the average accuracy is 87% with a sensitivity rate and a specificity rate of 98% and 17% 
respectively. It can be seen in this result that the proposed classifier has a high performance on 
predicting positive items. Meanwhile, 87% accuracy also proves the high performance of the 
classifier. However, the low specificity rate means the classifier features poor capability of 
distinguishing negative items from all data.  
This is because the negative data is less than positive data. The lack of negative data leads 
to the failure of our ANN model learning enough knowledge from the provided samples, 
therefore, the prediction on negative items is more inaccuracy. Another reason that should be 
noted is the features we extracted from medicine data could not represent the typical ones in 
the classify decision process. Although, the other result may be not good as anticipated, the 
sensitivity rate is out of expectation. The high accuracy on positive items strongly supports our 
hypothesis. 
Hence, the proposed ontology-based SE prediction model is preliminarily verified by ANN. 
However, in this procedure we did not revise the IFs due to the lack of the dataset, resulting in 
a weak prediction accuracy. Furthermore, the determination of the attributions is relatively broad. 
In another word, the attributions may be classified into more detailed catalogue such as hot, 
warm, neutral, cool, and cold. In this way, the ANN could learn more features of the dataset and 
give more precise predictions. Besides, according to other factors such as different length of 
treatment, it is of great significance that IFs should be evaluated with a weight vector or even 
tensor, which will influence the results of prescriptions and should be studied in next stage. 
5. Conclusion 
An ontology-based model for AI-assisted medicine side effect prediction is proposed in this 
paper. The drug, treatment, and prediction models are established to describe the methodology. 
And the SE prediction is carried out and verified by ANN, in which a simplified scheme containing 
latent attributions (Cold and Hot) and corresponding indicators (with or without SE) is 
investigated preliminarily. Clinic data coming from both safe and unsafe prescriptions is adopted 
to train the ANN, and thereafter, predict SE. The success of predicting whether a prescription 
will cause SE demonstrates the simplicity and effectiveness of this work, which should, however, 
be further improved as a powerful tool to predict more side effect syndrome. 
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